Encompass Health Co. (NYSE:EHC) Short Interest Up 6.3% in January

Encompass Health Co. (NYSE:EHC) was the target of a large growth in short interest in January. As of January 15th, there was short interest totalling 1,350,000 shares, a growth of 6.3% from the December 31st total of 1,270,000 shares. Approximately 1.4% of the company’s shares are short sold. Based on an average daily volume of 649,300 shares, the short-interest ratio is presently 2.1 days.

Encompass Health Price Performance

Shares of EHC opened at $100.20 on Tuesday. The firm has a market capitalization of $10.10 billion, a price-to-earnings ratio of 24.20, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. Encompass Health has a one year low of $70.83 and a one year high of $104.55. The stock’s fifty day moving average is $96.49 and its 200-day moving average is $94.91.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on EHC shares. Royal Bank of Canada lifted their price objective on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Barclays boosted their price target on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. KeyCorp upped their target price on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Finally, Truist Financial reiterated a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Nine analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $107.11.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of EHC. State Street Corp boosted its stake in Encompass Health by 0.7% during the third quarter. State Street Corp now owns 3,025,769 shares of the company’s stock valued at $292,410,000 after buying an additional 21,329 shares in the last quarter. Geode Capital Management LLC boosted its stake in Encompass Health by 1.2% during the third quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock valued at $161,781,000 after buying an additional 20,547 shares in the last quarter. Copeland Capital Management LLC boosted its stake in Encompass Health by 0.7% during the fourth quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company’s stock valued at $119,418,000 after buying an additional 8,548 shares in the last quarter. Point72 Asset Management L.P. boosted its stake in Encompass Health by 2,458.5% during the third quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after buying an additional 835,135 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. boosted its stake in Encompass Health by 0.4% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 769,716 shares of the company’s stock valued at $71,083,000 after buying an additional 2,904 shares in the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.